Folks, apologies once again for having let the site go down.

Winston Tsang was kind enough to have taken some of his own photos of the event; I particularly like this one:

ABSTRACT

Author Christopher Hitchens discusses his book "God Is Not Great: How Religion Poisons Everything" as a part of the Authors@Google series. The author of Why Orwell Matters and Letters to a Young Contrarian, Christopher Hitchens is a Vanity Fair contributing editor, a Slate columnist, and a regular contributor to The Atlantic Monthly. He has also written for The Nation, Granta, Harper's, The Washington Post, and is a frequent television and radio guest. Born in England, Hitchens was educated at Balliol College, Oxford, where he received a degree in philosophy, politics, and economics. He now lives in Washington, D.C., and he became a U.S. citizen in 2007. This event took place on August 16, 2007 at Google headquarters in Mountain View, CA.

ABSTRACT

The intrinsic genetic instability of cancer cells makes age-related cancers harder to ... all » postpone or treat than any other aspect of aging. Any therapy that a cancer can resist by activating or inactivating specific genes is unlikely to succeed long-term, because pre-existing cancer cells with the necessary gene expression pattern will withstand the therapy and proliferate. WILT (Whole-body Interdiction of Lengthening of Telomeres) seeks to pre-empt this problem by deleting from as many of our cells as possible the genes needed for telomere elongation. Cancers lacking these genes can never reach a life-threatening stage by altering gene expression, only by acquiring new genes, which is far more unlikely. Continuously-renewing tissues can be maintained by periodic reseeding with telomere elongation-incompetent stem cells that have had their telomeres lengthened in vitro with exogenous telomerase. I will describe why WILT may become a uniquely comprehensive anti-cancer modality, and the practicalities of performing it and avoiding side-effects.

ABSTRACT

Stem cell technology and the debate surrounding it has generated a great deal of excitement ... all » and controversy in recent years. The field is surrounded by misconceptions, hype and yet very significant potential. In this talk we'll cover: defining what are stem cells really and where do they come from... the differences between embryonic stem cells and 'adult stem cells' (i.e. derived from our own bone marrow, fat, umbilical cord blood, placentas and even our kids teeth) and emerging technologies to utilize these cells in powerful and novel ways. We'll cover current clinical uses of stem cells, ongoing clinical trials in regenerative medicine (i.e. using marrow derived cells to treat heart attacks, vascular disease, stroke and even diabetes), upcoming trials utilizing embryonic stem cells, and some of the likely near term and future applications as well as challenges remaining in order for this field to reach its full potential.

I bit the bullet and did the Facebook thing: it was damned near useless to me before, now it's indispensable. Having spent far too much time there, I'm turning my attention back here. More later, stay tuned...

ABSTRACT

It may seem premature to be discussing approaches to the effective elimination of human ... all » aging as a cause of death at a time when essentially no progress has yet been made in even postponing it. However, two aspects of human aging combine to undermine this assessment. The first is that aging is happening to us throughout our lives but only results in appreciable functional decline after four or more decades of life: this shows that we can postpone the functional decline caused by aging arbitrarily well without knowing how to prevent aging completely, but instead by increasingly thorough molecular and cellular repair. The second is that the typical rate of refinement of dramatic technological breakthroughs is rather reliable (so long as public enthusiasm for them is abundant) and is fast enough to change such technologies (be they in medicine, transport, or computing) almost beyond recognition within a natural human lifespan. In this talk I will explain, first, why (presuming adequate funding for the initial preclinical work) therapies that can add 30 healthy years to the remaining lifespan of healthy 55-year-olds may arrive within the next few decades, and, second, why those who benefit from those therapies will very probably continue to benefit from progressively improved therapies indefinitely and thus avoid debilitation or death from age-related causes at any age.

Ask a deeply religious Christian if he’d rather live next to a bearded Muslim that may or may not be plotting a terror attack, or an atheist that may or may not show him how to set up a wireless network in his house. On the scale of prejudice, atheists don’t seem so bad lately.

Scott Adams, Dilbert.Blog, "Atheists: The New Gays"